Stocks › OGN
Organon & Co.
OGN·NYSE·
United States·USD
United States·USD$13.74
+0.04 (+0.29%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
OGN
Organon & Co. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
OGNS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of OGN by members of U.S. Congress · 28 on record · 3 in the last 12 months
Whale Activity
Position changes in OGN reported for 2026-06-30 by 17 tracked institutional filers
- Increased2
- New1
- Held0
- Decreased5
- Closed2
- No prior filing7
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 32.1M | $434.0M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 15.1M | $204.9M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 11.9M | $161.3M | increased |
| MILLENNIUM MANAGEMENT LLC | 3.4M | $46.6M | decreased |
| KAHN BROTHERS GROUP INC | 2.7M | $36.2M | — |
| TIG Advisors, LLC | 1.4M | $19.0M | — |
| GFS Advisors, LLC | 1,267 | $12.3M | — |
| D. E. Shaw & Co., Inc. | 718.8K | $9.7M | decreased |
| P SCHOENFELD ASSET MANAGEMENT LP | 667.4K | $9.0M | — |
| Absolute Gestao de Investimentos Ltda. | 665.2K | $9.0M | — |
| CITADEL ADVISORS LLC | 344.4K | $4.7M | decreased |
| TWO SIGMA INVESTMENTS, LP | 241.4K | $3.3M | decreased |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by OGN insiders, by quarter · Form 4
Recent Insider Transactions
444 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Drinane Juliana PapaHead of Mfg & Supply | Sale | −14.8K | $13.57 | $200K | Aug 5, 2026 | Form 4 ↗ |
| Holzbaur LynetteSVP and Corporate Controller | Sale Amended | −26.4K | $13.35 | $353K | May 6, 2026 | Form 4 ↗ |
| Holzbaur LynetteSVP and Corporate Controller | Other Amended | +46 | $0.00 | $0 | May 6, 2026 | Form 4 ↗ |
| Holzbaur LynetteSVP and Corporate Controller | Purchase | +26.4K | $13.35 | $353K | May 6, 2026 | Form 4 ↗ |
| Drinane Juliana PapaInterim Head of Mfg & Supply | Tax withholding | −3,451 | $5.70 | $20K | Mar 31, 2026 | Form 4 ↗ |
| Drinane Juliana PapaInterim Head of Mfg & Supply | Option exercise | +10.1K | $0.00 | $0 | Mar 31, 2026 | Form 4 ↗ |
| Drinane Juliana PapaInterim Head of Mfg & Supply | Tax withholding | −2,185 | $5.70 | $12K | Mar 31, 2026 | Form 4 ↗ |
| Drinane Juliana PapaInterim Head of Mfg & Supply | Option exercise | +6,378 | $0.00 | $0 | Mar 31, 2026 | Form 4 ↗ |
| Arjona Ferreira Juan CamiloHead of R&D & CMO | Tax withholding | −4,820 | $5.70 | $27K | Mar 31, 2026 | Form 4 ↗ |
| Arjona Ferreira Juan CamiloHead of R&D & CMO | Option exercise | +13.4K | $0.00 | $0 | Mar 31, 2026 | Form 4 ↗ |
| Karp DanielExecutive VP, Corp. Dev. | Tax withholding | −2,105 | $5.70 | $12K | Mar 31, 2026 | Form 4 ↗ |
| Karp DanielExecutive VP, Corp. Dev. | Option exercise | +6,715 | $0.00 | $0 | Mar 31, 2026 | Form 4 ↗ |
| Karp DanielExecutive VP, Corp. Dev. | Tax withholding | −3,554 | $5.70 | $20K | Mar 31, 2026 | Form 4 ↗ |
| Karp DanielExecutive VP, Corp. Dev. | Option exercise | +11.3K | $0.00 | $0 | Mar 31, 2026 | Form 4 ↗ |
| Stahler Rachel AChief Information Officer | Tax withholding | −4,217 | $5.70 | $24K | Mar 31, 2026 | Form 4 ↗ |
| Stahler Rachel AChief Information Officer | Option exercise | +12.3K | $0.00 | $0 | Mar 31, 2026 | Form 4 ↗ |
| Stahler Rachel AChief Information Officer | Tax withholding | −2,246 | $5.70 | $13K | Mar 31, 2026 | Form 4 ↗ |
| Stahler Rachel AChief Information Officer | Option exercise | +6,555 | $0.00 | $0 | Mar 31, 2026 | Form 4 ↗ |
| WALSH MATTHEW MChief Financial Officer | Tax withholding | −7,380 | $5.70 | $42K | Mar 31, 2026 | Form 4 ↗ |
| WALSH MATTHEW MChief Financial Officer | Option exercise | +21.5K | $0.00 | $0 | Mar 31, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding OGN · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF iShares Trust | 15.8M | $214.2M | 0.19% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 8.3M | $112.8M | 0.00% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 6.0M | $81.6M | 0.04% | Jun 30, 2026 |
| VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS | 3.8M | $51.7M | 0.08% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 3.0M | $40.8M | 0.04% | Jun 30, 2026 |
| Nexpoint Merger Arbitrage Fund NexPoint Funds I | 2.7M | $36.6M | 2.46% | Jun 30, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF SPDR SERIES TRUST | 2.4M | $32.7M | 0.19% | Jun 30, 2026 |
| iShares S&P Small-Cap 600 Value ETF iShares Trust | 2.3M | $30.6M | 0.38% | Jun 30, 2026 |
| VANGUARD EQUITY INCOME FUND VANGUARD FENWAY FUNDS | 3.8M | $23.0M | 0.04% | Mar 31, 2026 |
| State Street(R) SPDR(R) S & P 600(TM) Small Cap Value ETF SPDR SERIES TRUST | 1.4M | $18.5M | 0.38% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list OGN's shares (CUSIP 68622V106), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming organon as client
- WILLIAMS AND JENSEN, PLLCORGANON · 2026 Q2 · BUD, HCR$50K
Filing ↗ - JEFFREY J. KIMBELL & ASSOCIATES, INC.ORGANON & CO. · 2026 Q2 · HCR, MMM$5K
Filing ↗ - ORGANON & CO.ORGANON & CO. · 2026 Q2 · MMM, BUD$320K
Filing ↗ - TIBER CREEK GROUPORGANON, LLC · 2026 Q2 · HCR, MMM, BUD$60K
Filing ↗ - TIBER CREEK GROUPORGANON, LLC · 2026 Q1 · HCR, MMM, BUD$60K
Filing ↗
Government Contracts
Federal awards to Organon & Co. · USAspending
No federal contract awards found for Organon & Co..
U.S. Patents
Recent USPTO applications naming Organon & Co.
No USPTO patent applications found for Organon & Co..
Annual Financials
From OGN's 10-K filings · XBRL
No annual XBRL figures on record for OGN. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in OGN's price history.
Material Events (8-K)
Corporate events filed with the SEC
About Organon & Co.
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersJERSEY CITY, NJ
SEC CIK0001821825 ↗